跳至主要内容
临床试验/ISRCTN03397663
ISRCTN03397663已完成不适用

Evaluation of the efficacy and safety of a Sheabutter extract on cold sores (herpes simplex labialis)

BSP Pharma A/S (Denmark)0 个研究点目标入组 160 人开始时间: 2005年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Subjects aged 18 and 75 years, in good general health who have a clinical history of recurrent herpes labialis, with at least six self reported episodes of herpes lesion in the past year and at least one recurrance every three months.

排除标准

  • 1. History of immunodeficiency
  • 2. Use of other antiviral agents (including herbal medications), anti-inflammatory medications, steroids or analgesics during the treatment period
  • 3. Known allergy to Sheabutter
  • 4. Liver function tests greater than 3 times the upper limit of normal at baseline
  • 5. Female participants who are lactating, pregnant or planning to become pregnant
  • 6. Participants who have participated in another clinical trial in the last 30 days
  • 7. Participants unwilling to comply with the study protocol
  • 8. Any other condition, which in the opinion of the investigators could compromise the study

研究者

发起方
BSP Pharma A/S (Denmark)

相似试验